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Background: Infectious diseases are a leading cause of morbidity among travelers to resource-limited regions and
primary prevention is a cornerstone to risk reduction. Chemoprophylaxis has been successfully utilized for specific diseases.
Methods: We assessed self-reported compliance to daily chemoprophylaxis among deployed US military personnel. A 21
item self-completed questionnaire was completed by military personnel during mid-deployment.
Results: The perception of high disease risk was associated with an increased likelihood of compliance with daily
chemoprophylaxis. However, 60 % of respondents stated they would not comply with a daily regimen.
Conclusions: These data highlight the complexity of perceived risk and the difficulties with prophylactic interventions.Background
Infectious diseases have been and remain a leading
cause of morbidity in travelers, including the deployed
military. In military populations, disease prevention has
emphasized preparation, education, personal protective
measures, vaccines, and chemoprophylaxis [1]. The ef-
fectiveness of these measures is often dependent on the
disease in question, though understanding the percep-
tions and attitudes towards primary prevention strat-
egies may enable the development of more targeted
interventions with higher success rates.
Vaccination has a clear history of reducing disease risk
for many diseases of military importance; however, for
several (malaria, travelers’ diarrhea, dengue fever, skin
infections, etc.) vaccines remain unavailable. In their ab-
sence, increased use of personal protection, vector control,
and chemoprophylaxis has reduced malaria incidence in
endemic regions [2]. In contrast, chemoprophylaxis is not
currently recommended for travelers’ diarrhea (TD), and
utilization of standard public health practices to minimize
disease risks has yielded little impact on TD incidence,* Correspondence: chad.k.porter2.civ@mail.mil
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ployed populations over the past two decades [3, 4]. In
addition to the burden of acute illness, evidence is increas-
ing on the importance of several sequelae of TD [5]. This,
coupled with the development of new non-absorbable an-
tibiotics, may modify the paradigm for chemoprophylaxis
[6]. In fact, such a study was recently conducted in active
duty military personnel deployed to Incirlik Air Base [7].
While the data from that study highlight the potential
efficacy of a specific chemoprophylactic regimen in cer-
tain regions, it is unclear whether comparable effective-
ness results would be borne out due to potential issues
with non-compliance. As such, we sought to assess fac-
tors associated with intended compliance to a daily
regimen of chemoprophylaxis for TD as well as malaria
(for comparison).
Methods
This was a cross-sectional study utilizing a convenience
sample of active duty US military personnel deployed to
Iraq, Afghanistan, and the surrounding region during an
in-processing brief as part of rest and recuperation
(R&R) at Camp As Sayliyah in Doha, Qatar as previously
described [4]. From April 2006 through September 2007,
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ments, perceived disease risk and likelihood of compli-
ance to a daily prophylactic was distributed to military
personnel. The questionnaires were voluntary and an-
onymous and were designed to assess potential future
compliance with a hypothetical travelers’ diarrhea prophy-
lactic compared to theoretical compliance with malaria
prophylaxis. Data were entered into Microsoft Excel
(Microsoft Inc., Redmond, WA) and verified by Naval
Medical Research Unit No. 3 (NAMRU-3) (Cairo,
Egypt) staff.
Descriptive analyses were performed using Student’s t
test for continuous variables and Pearson Chi-Square
tests for categorical variables. Perceived disease risk was
assessed by the question “What is your perceived risk of
acquiring Disease X”. Logistic regression models were
developed using backwards elimination to identify fac-
tors associated with an increased likelihood of compli-
ance to daily chemoprophylaxis for TD as well as
malaria. All variables with a p < 0.25 were retained in the
final model. Statistical significance was set at an alpha =
0.05 and all analyses were conducted using SAS v9.3
(Cary, NC).
Human subjects protection
This study was approved by the institutional review
board at the NAMRU-3, Cairo, Egypt.
Results
A total of 2235 questionnaires were distributed, com-
pleted and returned. Subjects were predominantly male
(84.2 %), in the Army (76.3 %) and enlisted (87.3 %). The
mean age of responders was 28.9 years. The majority of
respondents (71.8 %) were deployed in support of Oper-
ation Iraqi Freedom and were comprised of active duty
(62.9 %), reserve (18.5 %) and National Guard (17.1 %)
personnel. These demographic and populations charac-
teristics were representative of the deployment popula-
tion to the region.Table 1 Reported perceived disease risk among responders
Country predominately deployed Disease Perceiv
High r
Afghanistan Malaria 28 (9.7
Dysentery 19 (6.6
Watery diarrhea 26 (9.0
Iraq Malaria 11 (0.7
Dysentery 35 (2.2
Watery diarrhea 51 (3.2
Other/Unknown Malaria 4 (1.1)
Dysentery 5 (1.4)
Watery diarrhea 12 (3.3A significant proportion of subjects identified them-
selves as being at no risk for dysentery (46.7), watery
diarrhea (45.8), or malaria (48.6) regardless of the coun-
try to which the subject was predominately deployed,
while approximately 30 % did not know their risk for
these infectious diseases (Table 1). Perceived disease risk
varied by country of deployment with the highest rates
of ‘high risk’ observed in individuals deployed to
Afghanistan. The majority of subjects reported they
would not take a daily chemoprophylactic to prevent
diarrhea (61.5 %) or malaria (62.2 %) though subjects
were most likely (always or very likely) to comply with
daily chemoprophylaxis against malaria (17.1 %) rather
than for diarrhea (10.9 %) (data not shown).
After controlling for covariates, a high perceived risk
of diarrhea and malaria was associated with a significant
increase in the likelihood of compliance with daily
chemoprophylaxis compliance (OR: 3.8 and 4.9, respect-
ively) (Table 2). Additionally, military officers were more
likely to comply with daily chemoprophylaxis for diar-
rhea and malaria compared to enlisted respondents.
Similarly, those in the Navy and Air Force were more
likely to comply with chemoprophylaxis against malaria
compared to those in the Army.
Discussion
The majority of respondents indicated no perceived risk
to the diseases of interest including dysentery or watery
diarrhea. Recent studies have estimated travelers’ diar-
rhea rates among deployed military personnel to be ap-
proximately 30 cases per 100 person-months [3].
Because of the consistent and fairly high prevalence of
TD among similar populations, the low proportion per-
ceiving watery diarrhea and dysentery as “high risk” (less
than 5 %) is discordant with anticipated responses, and
it may be possible the term “risk” was perceived to mean
something other than the potential for incident illness.
This is supported by the minimal difference in perceived
high risk of watery diarrhea and malaria; a disease with aed Risk, n(%)
isk Low risk No risk Don’t know/missing
) 100 (34.7) 96 (33.3) 64 (22.2)
) 91 (31.6) 101 (35.1) 77 (26.7)
) 81 (28.1) 100 (34.7) 81 (28.1)
) 294 (18.6) 801 (50.7) 473 (30.0)
) 300 (19.0) 773 (49.0) 471 (29.8)
) 292 (18.5) 759 (48.5) 477 (30.2)
78 (21.2) 189 (51.4) 97 (26.4)
84 (22.8) 170 (46.2) 109 (29.6)
) 91 (24.7) 164 (44.6) 101 (27.5)
Table 2 Multivariate analyses of factors associated with the
likelihood of compliance to a once-a-day pill for prevention of
diarrhea or malaria
Significant Risk Factors OR (95 % CI) of increased likelihood of
compliance with daily chemoprophylaxis
Diarrhea Malaria
Perceived High Risk 3.78 (2.44–5.92) 4.88 (2.52–9.46)
Officer rank 1.61 (1.09–2.37) 2.21 (1.59–3.06)
Branch –
Army 1.00 (ref)
Air Force 2.79 (1.55–5.03)
Marines 0.64 (0.40–1.03)
Navy 1.62 (1.11–2.37)
Hosmer and Lemeshow Goodness-of-fit chi-square of 0.31 and 1.43 for
diarrhea and malaria models, respectively
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aria risks in the two theaters of operation is different [4].
In addition to low rates of perceived high disease risk,
a high proportion of respondents reported they would
never take a daily pill to prevent diarrhea or malaria. For
malaria, these estimates are consistent with historical re-
ports of low chemoprophylaxis compliance; however,
targeted intervention efforts have been shown to in-
crease compliance rates and this is why directly observed
therapy has been put into practice in the Department
of Defense [8]. Chemoprophylaxis is not currently rec-
ommended for TD, though the development of new
non-absorbable antibiotics and risk of post-infectious
sequelae may modify the paradigm [9]. Nonetheless,
given the challenges associated with behavioral modifi-
cation, a major emphasis on prevention should con-
tinue to be vaccination when feasible.
It is unclear if increased perceived disease risk would
meaningfully modify the likelihood of taking daily che-
moprophylaxis. For example, a population of vacationers
traveling for a significantly shorter period of time com-
pared to active duty military members may perceive
greater disease risk, thus resulting in increased compliance
of daily chemoprophylaxis. Additionally, it is unclear if
increased knowledge regarding the relationships between
illness prevention, infection prevention, and theoretical
sequelae prevention would alter attitudes toward daily
chemoprophylaxis. Furthermore, the reasons for varia-
bility in compliance across military-specific characteristics
are unclear highlight an area for future study. If preven-
tion of TD is shown in future studies to decrease sequalae,
issues of long-term daily chemoprophylaxis compliance
could be explored in deployment settings.
Conclusions
Given the overall low perceived risk of diarrhea and the
strong association between a high perceived disease riskand compliance, daily chemoprophylaxis may be a sub-
optimal means of disease prevention. Additional studies
are needed to better explore the knowledge, attitudes
and practice of US military personnel as well as other
travel populations.
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